Shopping Cart 0
Cart Subtotal
AED 0

Pharmaceuticals in Indonesia

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 3854
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Pharmaceuticals in Indonesia

 

Summary

 

Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Indonesian pharmaceuticals market had total revenues of USD 7.1m in 2018, representing a compound annual growth rate (CAGR) of 8.3% between 2014 and 2018.

- The performance of the market is forecast to accelerate, with an anticipated CAGR of 10.3% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 11.6m by the end of 2023.

- The market is anticipates to grow at a significant weight, and the lifting of restrictions on foreign ownership and concurrent measures undertaken by the government are underpinning future economic growth.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Indonesia

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Indonesia

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the Indonesia pharmaceuticals market by value in 2018?

- What will be the size of the Indonesia pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the Indonesia pharmaceuticals market?

- How has the market performed over the last five years?

- How large is Indonesia's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

PT Kalbe Farma Tbk

Novartis AG

Sanofi SA

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Indonesia pharmaceuticals market value: USD billion, 2014-18

Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: Indonesia pharmaceuticals market share: % share, by value, 2018

Figure 4: Indonesia pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in Indonesia, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2018

Figure 11: PT Kalbe Farma Tbk: revenues & profitability

Figure 12: PT Kalbe Farma Tbk: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Sanofi SA: revenues & profitability

Figure 16: Sanofi SA: assets & liabilities


List Of Table

List of Tables

Table 1: Indonesia pharmaceuticals market value: USD billion, 2014-18

Table 2: Indonesia pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: Indonesia pharmaceuticals market share: % share, by value, 2018

Table 4: Indonesia pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: PT Kalbe Farma Tbk: key facts

Table 6: PT Kalbe Farma Tbk: key financials (USD )

Table 7: PT Kalbe Farma Tbk: key financials (IDR)

Table 8: PT Kalbe Farma Tbk: key financial ratios

Table 9: Novartis AG: key facts

Table 10: Novartis AG: key financials (USD )

Table 11: Novartis AG: key financial ratios

Table 12: Sanofi SA: key facts

Table 13: Sanofi SA: key financials (USD )

Table 14: Sanofi SA: key financials (EUR)

Table 15: Sanofi SA: key financial ratios

Table 16: Indonesia size of population (million), 2014-18

Table 17: Indonesia gdp (constant 2005 prices, USD billion), 2014-18

Table 18: Indonesia gdp (current prices, USD billion), 2014-18

Table 19: Indonesia inflation, 2014-18

Table 20: Indonesia consumer price index (absolute), 2014-18

Table 21: Indonesia exchange rate, 2014-18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

PT Kalbe Farma Tbk

Novartis AG

Sanofi SA

Pharmaceuticals in Indonesia

 

Summary

 

Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Indonesian pharmaceuticals market had total revenues of USD 7.1m in 2018, representing a compound annual growth rate (CAGR) of 8.3% between 2014 and 2018.

- The performance of the market is forecast to accelerate, with an anticipated CAGR of 10.3% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 11.6m by the end of 2023.

- The market is anticipates to grow at a significant weight, and the lifting of restrictions on foreign ownership and concurrent measures undertaken by the government are underpinning future economic growth.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Indonesia

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Indonesia

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the Indonesia pharmaceuticals market by value in 2018?

- What will be the size of the Indonesia pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the Indonesia pharmaceuticals market?

- How has the market performed over the last five years?

- How large is Indonesia's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

PT Kalbe Farma Tbk

Novartis AG

Sanofi SA

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Indonesia pharmaceuticals market value: USD billion, 2014-18

Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: Indonesia pharmaceuticals market share: % share, by value, 2018

Figure 4: Indonesia pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in Indonesia, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2018

Figure 11: PT Kalbe Farma Tbk: revenues & profitability

Figure 12: PT Kalbe Farma Tbk: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Sanofi SA: revenues & profitability

Figure 16: Sanofi SA: assets & liabilities


List Of Table

List of Tables

Table 1: Indonesia pharmaceuticals market value: USD billion, 2014-18

Table 2: Indonesia pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: Indonesia pharmaceuticals market share: % share, by value, 2018

Table 4: Indonesia pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: PT Kalbe Farma Tbk: key facts

Table 6: PT Kalbe Farma Tbk: key financials (USD )

Table 7: PT Kalbe Farma Tbk: key financials (IDR)

Table 8: PT Kalbe Farma Tbk: key financial ratios

Table 9: Novartis AG: key facts

Table 10: Novartis AG: key financials (USD )

Table 11: Novartis AG: key financial ratios

Table 12: Sanofi SA: key facts

Table 13: Sanofi SA: key financials (USD )

Table 14: Sanofi SA: key financials (EUR)

Table 15: Sanofi SA: key financial ratios

Table 16: Indonesia size of population (million), 2014-18

Table 17: Indonesia gdp (constant 2005 prices, USD billion), 2014-18

Table 18: Indonesia gdp (current prices, USD billion), 2014-18

Table 19: Indonesia inflation, 2014-18

Table 20: Indonesia consumer price index (absolute), 2014-18

Table 21: Indonesia exchange rate, 2014-18

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

PT Kalbe Farma Tbk

Novartis AG

Sanofi SA